CDC\u2019s Investments to Combat Antibiotic Resistance Threats Nationwide : Nebraska

$1,270,585 Funding for AR Activities Fiscal Year 2017Funding to local health departments:$433,001 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, Nebraska improved its capacity to rapidly identify and respond to HAI/AR cases by making \u201cnightmare bacteria\u201d CRE reportable within 24 hours, making other gram-negative species likely to be multi-drug resistant reportable via electronic reporting, continuing development of an antibiotic susceptibility registry and validating CDC\u2019s NHSN HAI reporting.$643,000 - HAI/AR PREVENTION works best when public health and healthcare facilities partner together to implement targeted, coordinated strategies to stop infections and improve antibiotic use. The Nebraska Antimicrobial Stewardship Assessment and Promotion Program assessed and improved programs in 10 facilities and developed a website (https://asap.nebraskamed.com) to provide resources for others. Two hospitals were incentivized to participate in CDC\u2019s NHSN antibiotic use and resistance reporting.$194,584 - FOOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. Nebraska implemented whole genome sequencing of Listeria, Salmonella, Campylobacter and E. coli isolates submitted to its lab and began uploading sequence data into PulseNet for nationwide monitoring of outbreaks and trends. In Fiscal Year 2018, Nebraska will begin simultaneously monitoring these isolates for resistance genes. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread.Publication date from document properties.Nebraska-2017-CDC-AR-Investments.pd